Research Papers

25 of 1016 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
High glucose-induced injury in human umbilical vein endothelial cells is alleviated by vitamin D supplementation throug…
Liu Z; Sun H; Chen Y; He J; Zhu L; Yang B; Zhao W.
Diabetol Metab Syndr (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Insulin resistance-related features are associated with cognitive decline: a cross-sectional study in adult patients wi…
Ji X; Zou W; Fan L; Zhou Z; Zhu X; Li X.
Diabetol Metab Syndr (Unknown)
Published: 2024
4/6 Transparent
Registered Funding Declared
A comparative study of cardiovascular risk stratification methods in type 1 diabetes mellitus patients.
de Araujo FM; Comim FV; Lamounier RN; Pena NF; Fajardo VC; de Faria RBG; Silva YM; Lauria MW.
Diabetol Metab Syndr (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Lipid-lowering drugs and inflammatory bowel disease's risk: a drug-target Mendelian randomization study.
Zhao J; Chen R; Luo M; Gong H; Li K; Zhao Q.
Diabetol Metab Syndr (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Interventions in preconception and pregnant women at risk of gestational diabetes; a systematic review and meta-analysi…
Quotah OF; Andreeva D; Nowak KG; Dalrymple KV; Almubarak A; Patel A; Vyas N; Cakir GS; Heslehurst N; Bell Z; Poston L; White SL; Flynn AC.
Diabetol Metab Syndr (Unknown)
Published: 2024
4/6 Transparent
Registered Funding Declared
Current views on selenoprotein S in the pathophysiological processes of diabetes-induced atherosclerosis: potential the…
Yu SS; Du JL.
Diabetol Metab Syndr (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Pharmacotherapy for obesity: moving towards efficacy improvement.
Coutinho W; Halpern B.
Diabetol Metab Syndr (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Fasting hepatic insulin clearance reflects postprandial hepatic insulin clearance: a brief report.
Okura T; Nakamura R; Kitao S; Ito Y; Anno M; Matsumoto K; Shoji K; Matsuzawa K; Izawa S; Okura H; Ueta E; Kato M; Imamura T; Taniguchi SI; Yamamoto K.
Diabetol Metab Syndr (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Association between non-high-density lipoprotein to high-density lipoprotein ratio and reversion to normoglycemia in pe…
Mo Z; Han Y; Cao C; Huang Q; Hu Y; Yu Z; Hu H.
Diabetol Metab Syndr (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
A cross-sectional study on the prevalence of cardiovascular disease in elderly patients with long-term type 2 diabetes …
Arenas-León JL; Morales-Villegas EC; Cardona-Muñoz EG; Alcocer-Gamba MA; Ramirez-Contreras JP; Contreras-Sandoval AY; González-Galvez G.
Diabetol Metab Syndr (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Physical activity has a more beneficial effect on the risk of all-cause mortality in patients with metabolic syndrome t…
Lee CH; Han KD; Kwak MS.
Diabetol Metab Syndr (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Hyperglycemia and glucose variability are associated with worse survival in mechanically ventilated COVID-19 patients: …
van Herpt TTW; van Rosmalen F; Hulsewé HPMG; van der Horst-Schrivers ANA; Driessen M; Jetten R; Zelis N; de Galan BE; van Kuijk SMJ; van der Horst ICC; van Bussel BCT.
Diabetol Metab Syndr (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
Sodium-dependent glucose transporter 2 inhibitor alleviates renal lipid deposition and improves renal oxygenation level…
Zhang L; Wang T; Kong Y; Sun H; Zhang Y; Wang J; Wang Z; Lu S; Yu P; Zhou S.
Diabetol Metab Syndr (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
Mitigating iftar-related glycemic excursions in adolescents and young adults with type 1 diabetes on MiniMed™ 780G adva…
Elbarbary NS; Ismail EAR.
Diabetol Metab Syndr (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
Hypoglycemia in patients with type 2 diabetes mellitus during hospitalization: associated factors and prognostic value.
González-Vidal T; Rivas-Otero D; Gutiérrez-Hurtado A; Alonso Felgueroso C; Martínez Tamés G; Lambert C; Delgado-Álvarez E; Menéndez Torre E.
Diabetol Metab Syndr (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Adipose tissue specific insulin resistance and prognosis of nondiabetic patients with ischemic stroke.
Zhou Q; Yan H; Jin A; Meng X; Lin J; Li H; Wang Y; Pan Y.
Diabetol Metab Syndr (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
17-year follow-up of association between telomere length and all-cause mortality, cardiovascular mortality in individua…
Xiong L; Yang G; Guo T; Zeng Z; Liao T; Li Y; Li Y; Chen F; Yang S; Kang L; Liang Z.
Diabetol Metab Syndr (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Prevalence and predictors of chronic kidney disease among type 2 diabetic patients worldwide, systematic review and met…
Fenta ET; Eshetu HB; Kebede N; Bogale EK; Zewdie A; Kassie TD; Anagaw TF; Mazengia EM; Gelaw SS.
Diabetol Metab Syndr (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
Time in range and complications of diabetes: a cross-sectional analysis of patients with Type 1 diabetes.
Bezerra MF; Neves C; Neves JS; Carvalho D.
Diabetol Metab Syndr (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Cost-effectiveness of continuous glucose monitoring with FreeStyle Libre<sup>®</sup> in Brazilian insulin-treated patie…
Bahia L; Mello KF; Lemos LLP; Costa NL; Mulinari E; Malerbi DA.
Diabetol Metab Syndr (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Irisin suppresses pancreatic β cell pyroptosis in T2DM by inhibiting the NLRP3-GSDMD pathway and activating the Nrf2-Tr…
Li T; Yang J; Tan A; Chen H.
Diabetol Metab Syndr (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Remnant cholesterol and severity of nonalcoholic fatty liver disease.
Huang H; Wang J; Wu L; Ruan J; Hou L; Shen C; Xu C.
Diabetol Metab Syndr (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
LEP (G2548A-G19A) and ADIPOQ (T45G-G276T) gene polymorphisms are associated with markers for metabolic syndrome.
Ortega FL; Camberos AM; Arredondo MI; Magallanes NG; Meraz EA.
Diabetol Metab Syndr (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Multiple cardiometabolic diseases enhance the adverse effects of hypoalbuminemia on mortality among centenarians in Chi…
Li H; Wang S; Yang S; Liu S; Song Y; Chen S; Li X; Li Z; Li R; Zhao Y; Zhu Q; Ning C; Liu M; He Y.
Diabetol Metab Syndr (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Impact of insulin resistance on mild cognitive impairment in type 2 diabetes mellitus patients with non-alcoholic fatty…
Zhang H; Fareeduddin Mohammed Farooqui H; Zhu W; Niu T; Zhang Z; Zhang H.
Diabetol Metab Syndr (Unknown)
Published: 2023
3/6 Transparent
Funding Declared